Product Information
PREGABALIN 300 MG CAPSULE is a generic product labeled by Cipla USA Inc., priced at $0.0658 per EA under NDC 69097068505. Its NADAC has been published 295 times since Nov 4, 2020.
Strength
300 mg/1
Manufacturer
Cipla USA Inc.NDC
69097068505
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PREGABALINApproval Type
Generic (ANDA)
FDA Application
ANDA212280On Market Since
1/10/2020
Price Statistics
The NADAC for PREGABALIN 300 MG CAPSULE has been published 295 times since Nov 4, 2020, and over the history we have for it it has declined 53.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0658 per EA |
|---|---|
| All-time high | $0.1506 (Dec 16, 2020) |
| All-time low | $0.0628 (Nov 20, 2024) |
| 52-week high | $0.0803 |
| 52-week low | $0.0652 |
| Median price | $0.0963 |
| Average price | $0.0984 |
| Largest weekly change | +30.8% (Aug 21, 2024) |
| Weeks tracked | 295 |
| Tracking since | Nov 4, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the PREGABALIN capsules, CV market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PREGABALIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 300 MG CAPSULE, manufactured by Cipla USA Inc., is $0.0658 per EA (NDC 69097068505), effective Jun 24, 2026.
How has the price of PREGABALIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PREGABALIN 300 MG CAPSULE has declined 53.5%. It has been tracked across 295 weekly CMS publications since Nov 4, 2020.
What are the highest and lowest recorded NADAC prices for PREGABALIN 300 MG CAPSULE?
Since Nov 4, 2020, the NADAC for PREGABALIN 300 MG CAPSULE has ranged from a low of $0.0628 (Nov 20, 2024) to a high of $0.1506 (Dec 16, 2020), with a median of $0.0963 per EA.
Are there cheaper alternatives to PREGABALIN 300 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PREGABALIN 300 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures PREGABALIN 300 MG CAPSULE?
PREGABALIN 300 MG CAPSULE (NDC 69097068505) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification